Results 201 to 210 of about 457,723 (363)

A New Method to Control Ultrafiltration in Conventional Continuous Renal Replacement Therapy

, 2001
Moro O. Salifu, Eli A. Friedman
openalex   +1 more source

Patient Selection and Timing of Continuous Renal Replacement Therapy

Blood Purification, 2016
M. Ostermann, M. Joannidis, A. Pani, M. Floris, S. de Rosa, J. Kellum, C. Ronco   +6 more
semanticscholar   +1 more source

SF3A3 Drives Tumorigenesis in Endometrial Cancer by Enhancing c‐FOS Expression and Represents a Potential Therapeutic Target

Advanced Science, EarlyView.
The role of splicing factor 3A subunit 3 (SF3A3) in driving endometrial cancer (EC) progression and potential therapeutic interventions. SF3A3, a core component of the U2 small nuclear ribonucleoprotein (U2 snRNP), is upregulated in endometrial cancer (EC) and promotes tumor growth and cisplatin resistance. RNA‐binding protein immunoprecipitation (RIP)
Wei Yu, Yi Gu, Hengrui Zhang, Wunan Huang, Lei Sun, Liangjian Ma, Xiaolei Liang, Lexin Liu, Guiping Chen, Weihua Wang, Zhongkai Cao, Xue Li, Xiangjun Chen, Lidan Hu   +13 more
wiley   +1 more source

Legionella pneumonia complicated with severe acute kidney injury requiring continuous renal replacement therapy: a case series. [PDF]

J Med Case Rep
Rupasinghe S, Lemoh C.
europepmc   +1 more source

PIP5K1A Suppresses Ferroptosis and Induces Sorafenib Resistance by Stabilizing NRF2 in Hepatocellular Carcinoma

Advanced Science, EarlyView.
Inducing ferroptosis is a promising strategy for combating tumor resistance. Upregulated PIP5K1A competes with NRF2 for KEAP1 binding, which decreases the ubiquitination degradation of NRF2 and promotes its nuclear translocation, thereby suppressing ferroptosis, and ultimately driving hepatocellular carcinoma (HCC) tumorigeneses and sorafenib ...
Mengzhou Guo, Sinuo Chen, Jialei Sun, Ruchen Xu, Zhuoran Qi, Jie Li, Lianer Zhou, Yuan Fang, Tianshu Liu, Jinglin Xia   +9 more
wiley   +1 more source

Continuous renal replacement therapy for severe transient hyperammonemia in a preterm infant weighing 1120 g: A case report. [PDF]

J Int Med Res
Xu J, Liu J, Yang H, Zhang W, Chen D, Liu Z.   +5 more
europepmc   +1 more source

Multi‐Omics and ‐Organ Insights into Energy Metabolic Adaptations in Early Sepsis Onset

Advanced Science, EarlyView.
This study shows that patients at risk of sepsis have a distinct metabolite and lipid signature, including serine and aminoadipic acid, in their serum before clinical diagnosis. A mouse model of sepsis with a compatible serum signature reveals underlying metabolic changes, including mitochondrial adaptation, altered serine‐dependent purine metabolism ...
Lin‐Lin Xu, Zhengyuan Zhou, Sascha Schäuble, Wolfgang Vivas, Karen Dlubatz, Michael Bauer, Sebastian Weis, Mervyn Singer, Roman Lukaszewski, Gianni Panagiotou   +9 more
wiley   +1 more source

Self-perception of health and quality of life in patients on renal replacement therapy undergoing hemodialysis: a case-control study. [PDF]

Sao Paulo Med J
Gambin DJ, Dallepiane FG, Saraiva L, Führ MCS, Piovesan F, Mirek C, De Carli JP, Trentin MS.   +7 more
europepmc   +1 more source

ER‐phagy Activation by AMFR Attenuates Cardiac Fibrosis Post‐Myocardial Infarction via mTORC1 Pathway

Advanced Science, EarlyView.
By catalyzing FAM134B ubiquitination and activating ER‐phagy, AMFR alleviates progressive fibrosis and cardiac dysfunction by inhibiting the mTORC1 pathway. Consequently, these findings underscore the essential role of AMFR‐driven ER‐phagy in mitigating the progression of fibrotic responses, offering a potential therapeutic target for preventing heart ...
Zhixiang Wang, Kaifan Niu, Wei Liu, Xinyun Wang, Boshen Yang, Taixi Li, Yizhi Chen, Yuanyuan Jin, Yu Chen, Yangyi Lin, Xian Jin   +10 more
wiley   +1 more source

Development and validation of a predictive model for continuous renal replacement therapy in sepsis patients using the MIMIC-IV database. [PDF]

Sci Rep
Song B, Liu P, Liu C, Fu K, Zheng X, Liu Y.   +5 more
europepmc   +1 more source